Dexmedetomidine Hydrochloride Injection, Solution
Product Images NDC 63323-421
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine Hydrochloride (NDC 63323-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fresenius Kabi Logo (Dex10 0001 02)
462102 (Dex10 0001 03)
Dexmedetomidine HCl Injection, USP is a medication used for intravenous infusion. It comes in a 2mL single-dose vial containing 200 meg (base) that is required to be diluted before use. It is important to discard any unused portion. This medication is only available by prescription from Fresenius Kabi.*
462102 (Dex10 0001 04)
This is a description of a medication with the NDC code 63323-421-02. It is an injection, USP, that contains 118 mcg of Dexmedetomidine HCI per mL. The solution also contains sodium chloride, sodium acetate trihydrate, and acetic acid in water. This medication is sterile, preservative-free, and must be diluted before intravenous infusion. The usual dosage should be determined by consulting the package insert. The solution has a pH range of 4.5 to 7.0 and should be stored at 20° to 25°C (68°to 77°F). The container closure is not made with preservative-free rubber, and unused portions must be discarded.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.